Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Clozapine and the Effect of Pantoprazole
NCT07262736Phase 1Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clozapine in schizophrenia (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoints: Peak Plasma Concentration at 8 hours and Area Under the Plasma Concentration-Time Curve at 8 hours. Started Feb 2021; status: completed.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07262736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07262736.